Alphamab Oncology 관리
관리 기준 확인 2/4
Alphamab Oncology's CEO is Ting Xu, appointed in Nov 2008, has a tenure of 6.67 years. total yearly compensation is CN¥6.88M, comprised of 95.2% salary and 4.8% bonuses, including company stock and options. directly owns 33.06% of the company’s shares, worth HK$1.23B. The average tenure of the management team and the board of directors is 5.8 years and 5 years respectively.
주요 정보
Ting Xu
최고 경영자
CN¥6.9m
총 보상
| CEO 급여 비율 | 95.2% |
| CEO 임기 | 16yrs |
| CEO 소유권 | 33.1% |
| 경영진 평균 재임 기간 | 5.8yrs |
| 이사회 평균 재임 기간 | 5yrs |
최근 관리 업데이트
Recent updates
CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CN¥216m |
| Mar 31 2024 | n/a | n/a | -CN¥213m |
| Dec 31 2023 | CN¥7m | CN¥7m | -CN¥211m |
| Sep 30 2023 | n/a | n/a | -CN¥214m |
| Jun 30 2023 | n/a | n/a | -CN¥218m |
| Mar 31 2023 | n/a | n/a | -CN¥272m |
| Dec 31 2022 | CN¥7m | CN¥6m | -CN¥326m |
| Sep 30 2022 | n/a | n/a | -CN¥309m |
| Jun 30 2022 | n/a | n/a | -CN¥292m |
| Mar 31 2022 | n/a | n/a | -CN¥352m |
| Dec 31 2021 | CN¥7m | CN¥5m | -CN¥412m |
| Sep 30 2021 | n/a | n/a | -CN¥502m |
| Jun 30 2021 | n/a | n/a | -CN¥592m |
| Mar 31 2021 | n/a | n/a | -CN¥510m |
| Dec 31 2020 | CN¥5m | CN¥4m | -CN¥428m |
| Sep 30 2020 | n/a | n/a | -CN¥652m |
| Jun 30 2020 | n/a | n/a | -CN¥877m |
| Mar 31 2020 | n/a | n/a | -CN¥851m |
| Dec 31 2019 | CN¥5m | CN¥3m | -CN¥833m |
보상 대 시장: Ting's total compensation ($USD969.67K) is above average for companies of similar size in the Hong Kong market ($USD399.57K).
보상과 수익: Ting's compensation has increased whilst the company is unprofitable.
CEO
Ting Xu (51 yo)
16yrs
테뉴어
CN¥6,877,000
보상
Dr. Ting Xu, Ph D., serves Chief Executive Officer at Alphamab Oncology since October 1, 2018. He Founded Alphamab Oncology in November 2008.Dr. Xu serves as Executive Director at Alphamab Oncology since...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Founder | 16yrs | CN¥6.88m | 33.06% HK$ 1.2b | |
| VP of Corporate Operations & Executive Director | 6.1yrs | CN¥2.97m | 데이터 없음 | |
| Vice President of Government Affairs & Public Relations | 5.8yrs | 데이터 없음 | 데이터 없음 | |
| Senior Vice President of Business Development | 6.5yrs | 데이터 없음 | 데이터 없음 | |
| Chief Commercial Officer | 3yrs | 데이터 없음 | 데이터 없음 | |
| Joint Company Secretary | 4.3yrs | 데이터 없음 | 데이터 없음 | |
| Joint Company Secretary | less than a year | 데이터 없음 | 데이터 없음 |
5.8yrs
평균 재임 기간
51.5yo
평균 연령
경험이 풍부한 관리: 9966's management team is seasoned and experienced (5.8 years average tenure).
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Founder | 6.7yrs | CN¥6.88m | 33.06% HK$ 1.2b | |
| VP of Corporate Operations & Executive Director | 6.1yrs | CN¥2.97m | 데이터 없음 | |
| Independent Non-Executive Director | 5yrs | CN¥396.00k | 데이터 없음 | |
| Non-Executive Director | less than a year | 데이터 없음 | 0.11% HK$ 4.0m | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Independent Non-Executive Director | 5yrs | CN¥396.00k | 데이터 없음 | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Chairman of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Independent Non-Executive Director | 3.3yrs | CN¥378.00k | 데이터 없음 |
5.0yrs
평균 재임 기간
55yo
평균 연령
경험이 풍부한 이사회: 9966's board of directors are considered experienced (5 years average tenure).